Supreme Court Holds Invalid Cholesterol Drug Patent That Covered Millions of Undisclosed Antibodies

In Amgen Inc. v. Sanofi, the Supreme Court unanimously held that “[i]f a patent claims an entire class of processes, machines, manufactures, or compositions of matter, the patent specification must enable a person skilled in the art to make and use the entire class.” That is, “the specification must enable the full scope of the invention as defined by its claims….
By: Manatt, Phelps & Phillips, LLP